Dyne Therapeutics (DYN) Short Interest Ratio & Short Volume → FW: 234x Gain (From Weiss Ratings) (Ad) Free DYN Stock Alerts $26.08 +0.08 (+0.31%) (As of 05/3/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Dyne Therapeutics Short Interest DataCurrent Short Volume9,020,000 sharesPrevious Short Volume8,080,000 sharesChange Vs. Previous Month+11.63%Dollar Volume Sold Short$229.47 millionShort Interest Ratio / Days to Cover6.5Last Record DateApril 15, 2024Outstanding Shares86,180,000 sharesPercentage of Shares Shorted10.47%Today's Trading Volume761,928 sharesAverage Trading Volume1,882,175 sharesToday's Volume Vs. Average40% Short Selling Dyne Therapeutics ? Sign up to receive the latest short interest report for Dyne Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatDYN Short Interest Over TimeDYN Days to Cover Over TimeDYN Percentage of Float Shorted Over Time Ad Crypto Swap ProfitsClaim Your Complimentary Bitcoin RewardMany have already secured their free Bitcoin reward offered by our esteemed guest. How about you? In an effort to spread the word about our upcoming workshop, he's generously offering $10 in Bitcoin (BTC) to participants. Absolutely no strings attached.Secure Your Spot Now Dyne Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/20249,020,000 shares $229.47 million +11.6%N/A6.5 $25.44 3/31/20248,080,000 shares $229.39 million +18.5%16.2%4.7 $28.39 3/15/20246,820,000 shares $190.89 million +3.2%13.7%3.2 $27.99 2/29/20246,610,000 shares $177.81 million -8.8%16.6%3.3 $26.90 2/15/20247,250,000 shares $171.10 million -15.2%19.1%4 $23.60 1/31/20248,550,000 shares $182.97 million +7.3%28.8%4.9 $21.40 Get the Latest News and Ratings for DYN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Dyne Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 1/15/20247,970,000 shares $133.02 million -18.5%26.8%5.1 $16.69 6/30/20235,480,000 shares $61.65 million +12.5%17.0%10.2 $11.25 6/15/20234,870,000 shares $58.93 million -1.4%15.1%9.4 $12.10 5/31/20234,940,000 shares $64.37 million -1.0%15.8%12.1 $13.03 5/15/20234,990,000 shares $68.31 million +2.3%16.0%12.6 $13.69 4/30/20234,880,000 shares $50.56 million No Change15.3%13 $10.36 4/15/20234,880,000 shares $44.41 million +14.0%15.3%15.3 $9.10 3/31/20234,280,000 shares $49.31 million +5.2%13.5%12.5 $11.52 3/15/20234,070,000 shares $51.40 million +8.0%13.6%13.6 $12.63 2/28/20233,770,000 shares $48.56 million +1.9%12.7%11.4 $12.88 2/15/20233,700,000 shares $50.62 million +4.2%13.4%11.7 $13.68 1/31/20233,550,000 shares $51.83 million +25.0%13.0%11.7 $14.60 1/15/20232,840,000 shares $36.81 million +15.9%10.4%9.5 $12.96 12/30/20222,450,000 shares $28.40 million -11.2%8.9%8.7 $11.59 12/15/20222,760,000 shares $37.51 million +2.2%9.7%9 $13.59 11/30/20222,700,000 shares $31.59 million -5.3%9.5%11.1 $11.70 11/15/20222,850,000 shares $28.47 million +2.5%10.1%11.1 $9.99 10/31/20222,780,000 shares $31.69 million +23.6%9.7%10.3 $11.40 10/15/20222,250,000 shares $29.68 million +27.8%7.9%8.3 $13.19 9/30/20221,760,000 shares $22.35 million +38.6%6.2%6.7 $12.70 9/15/20221,270,000 shares $17.78 million +5.8%4.6%5.2 $14.00 8/31/20221,200,000 shares $11.76 million +17.7%4.4%5.1 $9.80 8/15/20221,020,000 shares $12.23 million +16.4%3.7%4.8 $11.99 7/31/2022876,500 shares $9.19 million -14.9%3.3%4.7 $10.49 7/15/20221,030,000 shares $10.56 million -73.0%3.8%5.8 $10.25 6/30/20223,820,000 shares $26.24 million +1.1%14.2%22.9 $6.87 6/15/20223,780,000 shares $20.87 million +139.2%14.0%23.2 $5.52 5/31/20221,580,000 shares $7.60 million -3.1%5.9%10.1 $4.81 5/15/20221,630,000 shares $9.10 million -2.4%6.1%10.4 $5.58 4/30/20221,670,000 shares $13.33 million +1.2%6.2%10.3 $7.98 4/15/20221,650,000 shares $15.81 million +1.2%6.1%8.6 $9.58 3/31/20221,630,000 shares $15.71 million -3.0%6.2%6.8 $9.64 3/15/20221,680,000 shares $14.50 million -28.8%6.4%7.1 $8.63 2/28/20222,360,000 shares $20.23 million +3.1%9.0%9.8 $8.57Could Your Accounts Be Frozen? (Ad)The US Dollar Is "Finished" A deteriorating economy, global instability, and a weakened banking system have pushed the U.S. financial system to the brink, imperiling the value of your savings and investments.Get your Free Wealth Protection Kit DYN Short Interest - Frequently Asked Questions What is Dyne Therapeutics' current short interest? Short interest is the volume of Dyne Therapeutics shares that have been sold short but have not yet been closed out or covered. As of April 15th, investors have sold 9,020,000 shares of DYN short. Learn More on Dyne Therapeutics' current short interest. What is a good short interest ratio for Dyne Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. DYN shares currently have a short interest ratio of 6.0. Learn More on Dyne Therapeutics's short interest ratio. Is Dyne Therapeutics' short interest increasing or decreasing? Dyne Therapeutics saw a increase in short interest during the month of April. As of April 15th, there was short interest totaling 9,020,000 shares, an increase of 11.6% from the previous total of 8,080,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Dyne Therapeutics' short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Dyne Therapeutics: Arvinas, Inc. (13.09%), Vera Therapeutics, Inc. (16.07%), Maravai LifeSciences Holdings, Inc. (5.93%), Deciphera Pharmaceuticals, Inc. (11.45%), Keros Therapeutics, Inc. (6.27%), Amphastar Pharmaceuticals, Inc. (11.01%), Rocket Pharmaceuticals, Inc. (12.12%), Indivior PLC (0.15%), TG Therapeutics, Inc. (25.55%), Avidity Biosciences, Inc. (11.15%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short Dyne Therapeutics stock? Short selling DYN is an investing strategy that aims to generate trading profit from Dyne Therapeutics as its price is falling. DYN shares are trading up $0.08 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Dyne Therapeutics? A short squeeze for Dyne Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of DYN, which in turn drives the price of the stock up even further. How often is Dyne Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including DYN, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: Arvinas Short Squeeze Vera Therapeutics Short Squeeze Maravai LifeSciences Short Squeeze Deciphera Pharmaceuticals Short Squeeze Keros Therapeutics Short Squeeze Amphastar Pharmaceuticals Short Squeeze Rocket Pharmaceuticals Short Squeeze Indivior Short Squeeze TG Therapeutics Short Squeeze Avidity Biosciences Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:DYN) was last updated on 5/4/2024 by MarketBeat.com Staff From Our PartnersBiden to Launch “FedNOW” [Move Your Money Now]Priority GoldElon to Transform U.S. Economy? Porter & CompanyGlobal crypto currency reset (41 major banks signed up)Stansberry ResearchAutomatic Income (from home)Awesomely, LLCFW: 234x GainWeiss RatingsCould Your Accounts Be Frozen?Allegiance GoldThe Gold Grab of the CenturyColonial MetalsStock-Picking AI Predicts #1 Stock of 2024Altimetry